Ignite Creation Date:
2024-05-05 @ 11:48 AM
Last Modification Date:
2024-10-26 @ 9:14 AM
Study NCT ID:
NCT00148395
Status:
COMPLETED
Last Update Posted:
2008-04-22
First Post:
2005-09-07
Brief Title:
Randomized Phase III-Study in Stage IIIb and IV Non-Small-Cell Lung Cancer Sequential Single-Agent vs Double-Agent vs Triple-Agent Therapy
Sponsor:
Aktion Bronchialkarzinom eV
Organization:
Aktion Bronchialkarzinom eV
Organization Data
Organization:
Aktion Bronchialkarzinom eV
Class:
OTHER
Study ID:
NSCLC 062001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Aktion Bronchialkarzinom eV
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None